Entrada Therapeutics, Inc. · NASDAQ:TRDA
Zeiher Bernhardt G bought 5,000 Entrada Therapeutics, Inc. shares (Form 4)
Traded May 20, 2026 · Filed May 21, 2026
On May 20, 2026, Zeiher Bernhardt G (Director) bought 5,000 Entrada Therapeutics, Inc. shares at US$5.86 for US$29,300, leaving 5,000 shares. Filed May 21, 2026 (Form 4).
- Bought
- 5,000 shares
- Price
- US$5.86
- Value
- US$29,300
- Holding after
- 5,000 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | Buy | 5,000 | US$5.86 | 5,000 | Indirect |
Source
Related
- Entrada Therapeutics, Inc.
- Zeiher Bernhardt G
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026